This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): OTX-CP07
Description: OTX-CP07 is a combination product with human embryonic cartilage progenitors manufactured from human embryonic stem cells (designated cell line 4D20.8) formulated with BioTime’s proprietary cell delivery device Renevia (formerly HyStem-C or HyStem-Rx).
HyStem offers a convenient delivery matrix and its in situ polymerization creates a biocompatible, resorbable, scaffold for cell proliferation and tissue regeneration.
Additional information available to subscribers only: